Chandigarh: For one leg to the R & D activity in the country, a synergy between institutions and industry is the need of the hour as research institutes, funds, while the industry has been a major user of research products.

Research institutes, including the Bangalore-based Indian Institute of Science (IISc) are now increasingly on the private sector to take joint R & D projects.

Thus, more than 400 companies from India and abroad was linked with the Institute for Research and Development in the area. The Institute is the implementation of joint projects and projects financed by the private sector.

There is a Times News Network, Prof. Goverdhan Mehta, director of the Indian Institute of Science (IISc), said: Under this initiative, more than eight major Indian companies have made themselves known primarily for setting instead of joint research centers at the Institute on the premises for the implementation of these two bases, and applied research. We are now working on joint projects in fields as diverse as bio-chemistry and electronic communication.”

The establishment of laboratories, in collaboration with private companies is step towards creating a science and technology park on campus. Among the companies that have completed their plans and sign an agreement with IISc belong Himachal Futuristic Communications Limited, Cadila, Bharat Biotech and Dorabji Tata Trust.

The Mohali-based national Institute for Training and Research-Based Pharmaceutical (Niper) is also closely linked to two major joint ventures for research in the pharmaceutical industry.

Institutions are, however, the aim being to play for real, since the beginning, especially in the areas of intellectual property rights.

”We are not very clear on the issue of IPR. We ensure that we yields and recognition of our contribution,’’said Mehta. He however added that the private sector has shown much on the support of science. ”The Indian industry must do more to science,”he said.

He also said that universities are required for the adoption of remedial measures at their end. For example, he said that the quality of research in universities has worsened during the year. ”The University portfolio in R & D is narrowed, and this is a national phenomenon. Universities are not the nature of the contribution it should have done.”

As corrective measures, he suggested adopting a three-pillar concept. He proposed the creation of the good nature of the infrastructure, production, promotion and maintenance of quality human resources and the availability of good nature of consumer research work. ”The management structure at the moment is not appropriate for R & D,”he said.

Alumni and provides the basis Niper course of the day, Mehta said that the there was a paradigm shift in drug development in the country during the last 10 years. He said that simple entries that could be used to synthesize complex molecules.

He is currently the detailed implementation of the assessment of biological molecules that are in the preclinical phase to examine the scope for further development. Niper director CL Kaul said that the Institute plans molecules license for commercial production at the end of the project.

In addition to these Niper also in an in vitro model of insulin resistance in skeletal muscle cells culture. It is now in the national process of creating a faculty of bio-equivalence. Kaul said that the Institute is currently working on a World Bank project, worth Rs 8.88 crore and had a turnover of Rs 4.79 crore during the year 2003.